INmune Bio Inc. operates as a clinical stage biotechnology company. The Company develops medicines to treat cancer. INmune Bio serves clients in the United States.
MarketWatch
CNBC
CNBC
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.